Management Change/Compensation (Form 8-K)

Item 5.02(b). Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Departure of Melinda Lackey as Legal & Administration, Corporate Secretary

On July 16, 2025, Melinda Lackey notified Alaunos Therapeutics, Inc. (the "Company") that, pursuant to Section 1 of the November 11, 2023 Consulting Agreement (the "Agreement") between the parties, she was terminating the agreement, effective 30 days from the date of the notice, or August 15, 2025 (the "Effective Date"). Concurrent with this notice, Ms. Lackey is resigning as Legal and Administrative Officer and as the Company's corporate secretary as of the Effective Date. Ms. Lackey's departure is not the result of any disagreement with the Company on any matter related to the Company's operations, policies or procedures.

No additional severance or other compensatory arrangements were made in connection with this termination, other than any accrued but unpaid compensation owed to Ms. Lackey through the Effective Date.